Loading...
Chemical structure of Mavodelpar

GC69437

Mavodelpar

Also known as sodium 2-[4-[(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-ylprop-1-ynyl)phenyl]prop-2-enoxy]-2-methylphenoxy]acetate

Mavodelpar (REN001) is a selective PPARδ agonist· It inhibits glomerular injury and renal fibrosis· Mavodelpar can be used for research on primary mitochondrial myopathy (PMM) and long-chain fatty acid oxidation disorders (LC-FAOD)

ChemicalCAS1604815-32-8MW537.55FormulaC31H29FNNaO5
CAS number
1604815-32-8
Molecular weight
537.55
Formula
C31H29FNNaO5
Solubility
DMSO ： 120 mg/mL (223·24 mM; Need ultrasonic)
InChIKey
FDJYWCAHISUZAI-MAOGHAJMSA-M
Catalogue number
GC69437
Brand
GLPBIO
Computed properties PubChem CID 122662515 · TPSA 71.1 Ų · H-bond donors 0 · H-bond acceptors 7
TPSA
71.1 Ų
H-bond donors
0
H-bond acceptors
7
Rotatable bonds
10
Heavy atoms
39

SMILES CC1=C(C=CC(=C1)OC/C=C(\C2=CC=C(C=C2)C#CCN3CCOCC3)/C4=CC=C(C=C4)F)OCC(=O)[O-].[Na+]

Computed descriptors from PubChem (CID 122662515), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.